1-(5-O-phosphono-beta-D-ribofuranosyl)-1,4-dihydropyridine-3-carboxamide
| CAS No. | 4229-56-5 |
|---|---|
| MDL No. | N/A |
| MF | C11H17N2O8P |
| MW | 336.23 |
| InChI Key | XQHMUSRSLNRVGA-TURQNECASA-N |
| CAS No. | 4229-56-5 |
|---|---|
| MDL No. | N/A |
| MF | C11H17N2O8P |
| MW | 336.23 |
| InChI Key | XQHMUSRSLNRVGA-TURQNECASA-N |
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
NMNH is a nicotinamide mononucleotide formed by hydride addition to position 4 of the pyridine ring of NMN(+). It functions as a metabolite and is related to NMN(+). It is the conjugate acid of NMNH(2-).
| CAS No. | 4229-56-5 |
|---|---|
| Product Name | 1-(5-O-phosphono-beta-D-ribofuranosyl)-1,4-dihydropyridine-3-carboxamide |
| Heavy Atom Count | 22 | Rotatable Bond Count | 5 |
| Atom Stereo Count | 4 | Bond Stereo Count | 0 |
| HBA | 7 | HBD | 5 |
| TPSA | 162.780 Ų | Charge | 0 |
| Exact Mass | 336.07225 | Complexity | 544.21 |
| pKa | 4.180 | XLogP | -1.869 |